AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AIM ImmunoTech Inc. Director's Dealing 2016

Jun 10, 2016

Director's Dealing

Opens in your device viewer

Issuer: HEMISPHERX BIOPHARMA INC (HEB)
CIK: 0000946644
Period of Report: 2016-06-08

Reporting Person: Equels Thomas K. (Director, CEO / President)

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-06-08	Options to buy Common Stock	$0.14	J	300000	Acquired	2026-06-08	Common Stock (300000)	Direct

F1: Stock Options issued per the employment agreement.